Bariatric Dose-ranging Study With Dexmedetomidine

Withdrawn before enrolling · Phase 4

Conditions studied: Abdominal Surgery Patients

In brief

After obtaining informed consent,80 morbidly obese ASA II-III patients undergoing laparoscopic bariatric surgery procedures would be randomly assigned to one of four study groups at UTSWMC at Dallas.Hemodynamic paarameters, recovery times, postoperative pain scores, the need for rescue analgesics and side effects will be recorded.The purpose of this study is to determine the optimal linfusion rate of dexmedetomidine for maintaining cardiovscular stability during general anesthesia.

Key facts

Study ID

NCT00363935

Run by

University of Texas Southwestern Medical Center

People needed

0

Starts

2007-01-01

Expected to finish

2007-01-01

Last updated by the study team

2019-01-16

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects may be included in the study only if they meet all of the following criteria:
• Age 18 to 70 years
• Undergo laparoscopic bariatric surgery requiring general anesthesia
• Be capable of giving informed consent
• ASA physical status I-III ( Appendix 1)

You may not qualify if…

• Subjects will be excluded from the study for any of the following reasons:
• With history of hypertension and allergy to dexmedetomidine
• Patients who have greater than first degree heart block.
• Performing major intracavitary surgery procedures
• Patients who are pregnant or breast-feeding
• History of alcohol or drug abuse

Where it is running

• The University of Texas Southwestern MedicalCenter at Dallas — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.